Ultrasound assessment of ovarian cancer risk in postmenopausal women with CA125 elevation
Open Access
- 25 June 1999
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 80 (10), 1644-1647
- https://doi.org/10.1038/sj.bjc.6690575
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort studyBMJ, 1996
- Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre‐operative diagnosis of pelvic massesBJOG: An International Journal of Obstetrics and Gynaecology, 1996
- Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125.Journal of Clinical Oncology, 1996
- Defining progression of ovarian carcinoma during follow-up according to CA 125: A North Thames Ovary Group studyAnnals of Oncology, 1996
- Preoperative CA 125: An Independent Prognostic Factor in Patients With Stage I Epithelial Ovarian CancerObstetrics & Gynecology, 1995
- Serum Half-Life of CA 125 during Early Chemotherapy as an Independent Prognostic Variable for Patients with Advanced Epithelial Ovarian Cancer: Results of a Multicentric Italian StudyGynecologic Oncology, 1995
- Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography.BMJ, 1993
- A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancerBJOG: An International Journal of Obstetrics and Gynaecology, 1990
- Transabdominal ultrasound screening for early ovarian cancer.BMJ, 1989
- MULTIMODAL APPROACH TO SCREENING FOR OVARIAN CANCERThe Lancet, 1988